Elosulfase Alfa 1 mg/ml
“Elosulfase alfa is demonstrated for the treatment of mucopolysaccharidosis type IVA (MPS IVA; Morquio Asyndrome) in patients all things considered.
The accompanying advances are prescribed for the dosing and organization of elosulfase alfa and depend on the Summary of Product Characteristics.
Elosulfase alfa treatment ought to be administered by a doctor experienced in the administration of patients with Morquio An or other acquired metabolic maladies. Organization of elosulfase alfa ought to be done by a properly prepared medicinal service proficient with the capacity to oversee restorative crises.”
